Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of meningeal involvement in Wegener's granulomatosis with infliximab.

Literature DB >> 16611871

Successful treatment of meningeal involvement in Wegener's granulomatosis with infliximab.

J Hermann, P Reittner, M Scarpatetti, W Graninger.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 16611871 PMCID： PMC1798150 DOI： 10.1136/ard.2005.043885

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

9 in total

1. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

Authors: Andras Komocsi; Peter Lamprecht; Elena Csernok; Antje Mueller; Konstanze Holl-Ulrich; Ulrike Seitzer; Frank Moosig; Armin Schnabel; Wolfgang Ludwig Gross
Journal: Am J Pathol Date: 2002-05 Impact factor: 4.307

2. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Authors: J H Stone; G S Hoffman; P A Merkel; Y I Min; M L Uhlfelder; D B Hellmann; U Specks; N B Allen; J C Davis; R F Spiera; L H Calabrese; F M Wigley; N Maiden; R M Valente; J L Niles; K H Fye; J W McCune; E W St Clair; R A Luqmani
Journal: Arthritis Rheum Date: 2001-04

3. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors: R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal: Arthritis Rheum Date: 1990-08

Review 4. Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors: J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal: Arthritis Rheum Date: 1994-02

5. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis.

Authors: K de Groot; D K Schmidt; A C Arlt; W L Gross; E Reinhold-Keller
Journal: Arch Neurol Date: 2001-08

6. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.

Authors: E Reinhold-Keller; K de Groot; K Holl-Ulrich; A C Arlt; M Heller; A C Feller; W L Gross
Journal: Clin Exp Rheumatol Date: 2001 Sep-Oct Impact factor: 4.473

7. Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis.

Authors: P Lamprecht; J Voswinkel; T Lilienthal; B Nolle; M Heller; W L Gross; A Gause
Journal: Rheumatology (Oxford) Date: 2002-11 Impact factor: 7.580

8. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

Authors: E Reinhold-Keller; N Beuge; U Latza; K de Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal: Arthritis Rheum Date: 2000-05

9. Etanercept plus standard therapy for Wegener's granulomatosis.

Authors:
Journal: N Engl J Med Date: 2005-01-27 Impact factor: 91.245